Publications & Presentations Our innovative development programs are backed by sound scientific research. Filter by All Publications Data Presentations A Single and Repeat-Dose Study of RZ358 in Patients with Post-Gastric Bypass Hypoglycemia (PGBH): Results of Population PK/PD Modeling Yongjun Hu PhD et al. ENDO 03/20/21 Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia in Patients with Congenital Hyperinsulinism Davelyn Eaves Hood MD et al. ESPE 2021 Single Dose Studies of RZ358 in Patients with Congenital Hyperinsulinism: Results of Population PK/PD Modeling and Simulation in Adult and Pediatric Patients Daniel Epling et al. Pediatric Endocrine Society (PES) 05/30/20 RZ358-606 RIZE Study: An Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism Nevan Charles Elam et al. Data Call 05/01/20 Targeting rare and metabolic diseases with transformative therapies Company Internal Biopharma Dealmakers 11/2019 Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers Kirk W. Johnson et al. The Journal of Clinical Endocrinology & Metabolism 08/2017 XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial Rajneesh Nath et al. ENDO 2015 Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: A potential new approach for the treatment of hyperinsulinemic hypoglycemia John A Corbin et al. mAbs 01/2014 12
